RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CANF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Can-Fite BioPharma Ltd as stock downgraded to Buy Candidate.
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 06, 2024 Gain 4.23% PDF

The Can-Fite BioPharma Ltd stock price fell by -1.77% on the last day (Thursday, 28th Mar 2024) from $2.26 to $2.22. During the last trading day the stock fluctuated 3.15% from a day low at $2.22 to a day high of $2.29. The price has fallen in 6 of the last 10 days but is still up by 3.74% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -4 thousand shares and in total, 7 thousand shares were bought and sold for approximately $16.00 thousand.

The stock lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.07% during the next 3 months and, with a 90% probability hold a price between $2.30 and $2.49 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CANF Signals & Forecast

The Can-Fite BioPharma Ltd stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.21 and $2.13. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -1.77%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Can-Fite BioPharma Ltd stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.11 and $2.10. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Can-Fite BioPharma Ltd finds support just below today's level at $2.11. If this is broken, then the next support from accumulated volume will be at $2.10 and $2.06.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.0700 between high and low, or 3.15%. For the last week the stock has had daily average volatility of 3.40%.

Our recommended stop-loss: $2.12 (-4.65%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (CANF) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Can-Fite BioPharma Ltd to open at $2.24, and during the day (based on 14 day Average True Range), to move between $2.13 and $2.31, which gives a possible trading interval of +/-$0.0871 (+/-3.92%) up or down from last closing price. If Can-Fite BioPharma Ltd takes out the full calculated possible swing range there will be an estimated 7.85% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.23 (0.45%) than the support at $2.11 (5.18%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Can-Fite BioPharma Ltd stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Can-Fite BioPharma Ltd stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 2.591 Buy Candidate Downgraded

Predicted Opening Price for Can-Fite BioPharma Ltd of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$2.24 ( 1.05%) $2.22

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CANF

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.31 4.20 %
R2 2.29 3.00 %
R1 2.27 2.26 %
Current price: 2.22
Support S1 2.22 -0.153 %
S2 2.20 -0.90 %
S3 2.17 -2.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.26 1.80 %
R2 2.25 1.35 %
R1 2.23 0.450 %
Current price 2.22
Support S1 2.11 -5.18%
S2 2.10 -5.41%
S3 2.06 -7.21%

FAQ

What is the symbol for Can-Fite BioPharma Ltd Stock and on which exchange is it traded?
The symbol for Can-Fite BioPharma Ltd is CANF and it is traded on the NYSEMKT (NYSE American).

Should I buy or sell Can-Fite BioPharma Ltd Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Can-Fite BioPharma Ltd stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

How to buy Can-Fite BioPharma Ltd Stock?
Can-Fite BioPharma Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Can-Fite BioPharma Ltd Stock.

What's the current price of Can-Fite BioPharma Ltd Stock?
As of the end of day on the 2024-03-28, the price of an Can-Fite BioPharma Ltd (CANF) share was $2.22.

What is the 52-week high and low for Can-Fite BioPharma Ltd Stock?
The 52-week high for Can-Fite BioPharma Ltd Stock is $3.33 and the 52-week low is $1.52.

What is the market capitalization of Can-Fite BioPharma Ltd Stock?
As of the 2024-03-28, the market capitalization of Can-Fite BioPharma Ltd is 11.079M.

When is the next earnings date for Can-Fite BioPharma Ltd?
The upcoming earnings date for Can-Fite BioPharma Ltd is Apr 04, 2024.
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT